END-AF 1
Clinical randomised Phase II trial of AP31969 versus Placebo for Rhythm control of atrial fibrillation
- Stadium
- inclusie
- Middel
- AP31969
- Populatie
- Ritme
- Fase
- II
- First Patient In
- 24 november 2025
- Last Patient In
- 31 december 2026
- Last Patient Last Visit
- 1 mei 2027
Inclusieperiode, nog 224 dagen over
Studiedirecteur
dr. R.G. Tieleman
Cardioloog
Contact Kantoor
